Skip to main content

International scientific guideline: Treatment and prophylaxis of respiratory syncytial virus (RSV) disease

EMA/CHMP/257022/2017 adopted by the Therapeutic Goods Administration (TGA)

Help us improve the Therapeutic Goods Administration site